Correction to: Nature Communications https://doi.org/10.1038/s41467-022-34477-1, published online 09 November 2022
The original version of this article contained an error in the Methods section which incorrectly omitted “Cord blood units were obtained from Anthony Nolan Cell Therapy Centre (ANCTC).” From page 9, Method section, subsection “Generation of humanised mice and their treatment with Abatacept and IgG-(IL-2)2”.
This now reads “….CD34 Microbead Kit UltraPure (Miltenyi Biotec). Cord blood units were obtained from Anthony Nolan Cell Therapy Centre (ANCTC). On some occasions…”
This has been corrected in both the PDF and HTML versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Wang, C.J., Petersone, L., Edner, N.M. et al. Author Correction: Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity. Nat Commun 14, 5724 (2023). https://doi.org/10.1038/s41467-023-41483-4
Published:
Version of record:
DOI: https://doi.org/10.1038/s41467-023-41483-4
